A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study
A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study
Fatima Jamali
1
, PhD ;
Mayis Aldughmi
2
, PhD ;
Mohammad W Khasawneh
1
, MD ;
Said Dahbour
3, 4
, MD ;
Alaa A Salameh
1
, MSc, PT ;
Abdalla Awidi
1, 5
, MD
1
Cell Therapy Center, University of Jordan, Amman, Jordan
2
Department of Physiotherapy, School of Rehabilitation Sciences, University of Jordan, Amman, Jordan
3
Medical Faculty, University of Jordan, Amman, Jordan
4
Neurology Division, Jordan University Hospital, Amman, Jordan
5
Hematology Department, Jordan University Hospital, Amman, Jordan